Among other proposals, she said NRI portfolio route would be merged with the FPI route for seamless investment in stock markets.
Around 70 companies have received IPO clearance from markets regulator Sebi, but are waiting for election results.
Elder Pharmaceuticals Ltd has entered into an alliance with US-based Blistex Inc to manufacture and introduce the latter's entire range of lip care products in India.\n\n\n\n
NSE's board was to approve on Friday the annual financial statement for the year ended March 31, 2019, but it decided to defer the matter till its legal team firmed up a view on Sebi's order, sources said.
According to Merrill Lynch (BofA-ML) report, Domestic capital markets are likely to remain volatile in the September-November period due to factors like US Fed's policy action, second quarter corporate earnings and Bihar state elections.
Even those with a 2G connection can use the platform.
In recent past, midcap stocks have performed well, say experts.
Sources at the NSE as well as the President's office rejected media reports that Kovind's pulling out of the event had to do with reasons other than his packed itinerary this week.
The combined market capitalisation of the 21 listed PSU banks declined by about Rs 76,000 crore to Rs 425,800 crore during the month.
The biggest spend (Rs 4,406 crore) was for Schedule VII (II), which involves "promoting education, including special education and employment enhancing vocation skills, especially among children, women, elderly and the differently abled and livelihood enhancement projects". The FY19 spend was 17.2 per cent higher than Rs 1,0128.3 crore spent during the previous year.
The Sensex soared 402 points higher to end at 25,720 and the Nifty surged 130 points to close at 7,819.
Experts said equity raising was also hampered due to flight of capital from foreign investors. FIIs have sold more $500 million (Rs 3,200 crore) in October.
The stock market watchdog had said any adverse findings by other regulators might have a bearing on the exchange.
The S&P BSE Midcap and the S&P BSE Smallcap indices under-performed to lose 0.8% and 1.6%
Take part in the growth story, Amit A Shah tells Corporate India.
If you want to buy into the stock markets don't wait for tomorrow. The right time to buy stocks is NOW. And here's why...
Above normal monsoon forecast and strength in Asian equities lifted sentiments.
PSU bank shares were the top gainers on hopes of a rate by the RBI on easing consumer inflation
'There is a huge tax differential of 15% to 20% depending on income classification.'
Officials said Sebi is closely in touch with RBI on the market developments.
MCX-SX on Friday said the rights issue would now close on April 17.
At the end of October, Sri Lanka President Maithripala Sirisena handed over the deeds for the transfer of 116 hectares in Colombo Port City to China Harbour Engineering Company on a 99-year lease to build a financial centre.
Ashok Leyland, ITD Cementation India have more than doubled.
If you leave too much money lying in your trading account or hand over your securities to brokers, there is always the risk that they could use it to trade in the markets.
Analysts say those taking exposure through stocks could look at firms focused on domestic business
Sensex gains 2.4%, Nifty crosses 7,000; investors feel exit polls have vindicated their stand
Among the Sensex 30 stocks, new entrant Sesa Goa soared 22 per cent to Rs 187, while TCS rose 11 per cent to Rs 2,023.
A special audit will look into any pricing anomalies in the transactions between the two, according to a source. FTIL had a contract for helping the exchange with its technology needs.
Officials said Sebi first proposed to the FinMin to amend the relevant provisions in the Sebi Act to discontinue RBI's representation on its board, as it already has adequate presence of government nominees and in its over 25 years of existence the regulator has evolved as an "effective and one of the best in the world".
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances